CDH2 and metastatic malignant neoplasm: N-cadherin engagement has been shown to promote survival through the activation of the PI3- kinase/Akt and subsequent phosphorylation of the pro-apoptotic protein Bad in metastatic cancer cells [7] and in vein smooth muscle cells [45].